$110.4 Million

Alpha Teknova, Inc.

Initial Public Offering

Lead Left Bookrunner, June 2021

Alpha Teknova, Inc.

Alpha Teknova, Inc. (“Teknova” or the “Company”) is a leading life sciences company which provides critical reagents to enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its 3,000 active customers span the entire continuum of the life sciences market and include leading pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. The Company is built around proprietary manufacturing processes that are highly adaptable and versatile, which enable the Company to manufacture and deliver high quality, custom, made-to-order products in a short turnaround time and at scale, across all stages of development, including commercialization.